|
HS Code |
488096 |
| Generic Name | Demeclocycline Hydrochloride |
| Drug Class | Tetracycline antibiotic |
| Chemical Formula | C21H21ClN2O8·HCl |
| Molecular Weight | 480.87 g/mol |
| Route Of Administration | Oral |
| Main Indication | Treatment of bacterial infections |
| Mechanism Of Action | Inhibits bacterial protein synthesis |
| Typical Dosage Form | Tablet |
| Common Side Effects | Photosensitivity, nausea, diarrhea |
| Contraindications | Pregnancy, children under 8 years, hypersensitivity to tetracyclines |
As an accredited Demeclocycline Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle labeled "Demeclocycline Hydrochloride 150 mg," contains 100 tablets, with tamper-evident seal and lot/expiry details. |
| Shipping | Demeclocycline Hydrochloride is shipped in tightly sealed containers to protect from light and moisture. It is typically transported at controlled room temperature, avoiding excessive heat. Proper hazard labeling and documentation are included, in compliance with regulatory requirements for pharmaceutical chemicals. Handle with care and refer to the Safety Data Sheet for additional shipping information. |
| Storage | Demeclocycline Hydrochloride should be stored at controlled room temperature, preferably between 20°C and 25°C (68°F–77°F). Protect from moisture, heat, and light. Keep the container tightly closed when not in use. Store in a dry place and avoid freezing. Ensure it is kept out of reach of children and is not exposed to extreme environmental conditions. |
|
Purity 98%: Demeclocycline Hydrochloride with a purity of 98% is used in the formulation of antibiotic tablets, where it ensures consistent therapeutic efficacy and patient safety. Molecular Weight 464.87 g/mol: Demeclocycline Hydrochloride with a molecular weight of 464.87 g/mol is used in pharmacokinetic studies, where it enables precise dosing calculations and reliable bioavailability assessment. Stability Temperature 25°C: Demeclocycline Hydrochloride stable at 25°C is used in long-term pharmaceutical storage, where it maintains its potency and shelf life. Particle Size <10 μm: Demeclocycline Hydrochloride with particle size less than 10 μm is used in injectable formulations, where it enhances suspension uniformity and improves bio-distribution. Solubility in Water 10 mg/mL: Demeclocycline Hydrochloride with solubility of 10 mg/mL in water is used in solution-based drug preparations, where it ensures rapid dissolution and effective systemic delivery. Melting Point 214°C: Demeclocycline Hydrochloride with a melting point of 214°C is used in high-temperature sterilization processes, where it allows for heat-resilient formulation without degradation. Assay ≥ 99%: Demeclocycline Hydrochloride with an assay of at least 99% is used in clinical trial supplies, where it guarantees qualified content and regulatory compliance. Residual Solvent <0.5%: Demeclocycline Hydrochloride with residual solvent below 0.5% is used in pediatric pharmaceutical products, where it minimizes toxicity risk and meets stringent quality standards. |
Competitive Demeclocycline Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Demeclocycline Hydrochloride holds a real spot in clinical treatment, especially in managing certain infections. With decades of use behind it, it stands out because it never got swallowed up by every new antibiotic trend. This older yet trustworthy antibiotic belongs to the tetracycline family. That makes it part of a class of drugs doctors have leaned on for quite a while. Those who have spent time in hospital wards or pharmacy shelves usually know it as the steady choice for cases where a gentle nudge against bacteria works better than an all-out assault. Its unique chemistry makes it effective against a wide spectrum of bacteria, including some strains that dodge other antibiotics.
You notice right away that Demeclocycline Hydrochloride isn’t the drug of first resort or the one most folks talk about at healthcare seminars, but its role isn’t about being flashy. Specialists and hospitals reach for it when facing complex problems, especially cases where patients can’t tolerate more aggressive drugs or deal with infections that ignore mainstream tetracyclines. The chemical structure in this compound, marked by a specific arrangement of hydrochloride salt, impacts its absorption, how it moves through the body, and the timeline you can rely on for treatment.
Model variations don’t play out the same way as with appliances or electronics, but different suppliers still offer it in slightly varying concentrations and forms. In most cases, it's available in oral tablet form, ranging from 150 mg to 300 mg. This makes dosing predictable for outpatient settings and clear for clinicians. Unlike newer antibiotics developed to punch through every resistance barrier, Demeclocycline Hydrochloride sticks with its old-school DNA. It doesn’t aim to solve all bacterial infections, but its focused effect on certain pathogens earns it respect. Especially in stubborn urinary tract infections, acne forms, and respiratory tract situations, this antibiotic wins points for reliability. Its effect extends to off-label uses as well, most notably in treating hyponatremia caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Here, it acts quite differently from other tetracyclines, thanks to its action on kidney water regulation.
Most people who handle this antibiotic every day learn that its differences run deeper than just brand name or generic label. Demeclocycline Hydrochloride sets itself apart by how it blocks protein synthesis in bacteria. Doctors notice the difference in patient outcomes, especially when facing organisms that outsmart typical penicillins or cephalosporins. This gives a sense of versatility; you can’t just swap in any tetracycline and expect the same outcome. Over time, most veterans in infectious disease circles discover that Demeclocycline Hydrochloride holds onto effectiveness in certain resistant cases that frustrate other options.
People who work behind the counter or mix up doses in the pharmacy know this product by feel, not just by label or color of the box. A tablet’s specifications reach from its core structure—the yellow crystalline powder, characteristic bitterness, and careful packaging to protect it from light. These details matter, particularly since the drug reacts poorly to sunlight. Its stability calls for attention during storage in hospitals, clinics, and pharmacies. You can't just leave the bottle on the counter near a window.
From a pharmacological standpoint, this compound travels well in the body, binding to plasma proteins and spreading across tissues. The half-life—roughly 10 to 16 hours in people with healthy kidneys—means patients can take it twice or three times a day, which frees up schedules and makes adherence less of a headache. Because it doesn’t break down rapidly in the liver or kidneys, adjustments become important in specific patients, particularly those with advanced renal issues. I’ve seen clinicians monitor their patients’ kidney function and electrolytes regularly, especially for those with liver disease or elderly folks adjusting to new medication routines.
Sometimes, the simplest features attract the most praise. Clear dosing instructions, a predictable onset of action, and an understandable list of side effects give this drug a practical twist. Doctors know they don’t have to wade through endless updates or unpredictable interactions. People talk openly about its sunlight sensitivity, teaching patients early on to avoid prolonged sun exposure and reporting any strange rashes or burning sensations.
Antibiotics come in waves. Each year, new names snatch headlines promising fewer side effects or broader coverage against new bacterial threats. Demeclocycline Hydrochloride stands apart for a different reason: it sticks with what works. Unlike minocycline, doxycycline, and other newer tetracyclines, this compound doesn’t dissolve as quickly, so its effect lasts a bit longer. You can see the difference most clearly in clinical niches. Physicians turn to doxycycline for malaria prevention or acute tickborne illnesses, while demeclocycline rarely sees action there because its action profile doesn’t fit those needs.
Demeclocycline Hydrochloride doesn’t try to compete head-to-head with broad-spectrum, next-generation antibiotics. Its strengths come from stability and proven track records. For people allergic to penicillins or cephalosporins, or when bacterial resistance rules out those usual suspects, Demeclocycline Hydrochloride frequently becomes the quiet hero. Its lower lipophilicity compared to minocycline means it crosses fewer central nervous system barriers, helping to dodge some side effects in sensitive patients. Doctors can use this to their advantage, especially when tailoring therapy for older patients, children above a certain age, or those with complex multi-drug histories.
In day-to-day terms, hospitals stock this drug for more than just infection emergencies. Its role in SIADH offers an answer when hormone imbalances throw off water balance. Working in a facility that handles a wide range of patient needs, I have seen this product bridge the gap in cases where other medications fail to restore sodium balance or cause intolerable side effects. Here, Demeclocycline Hydrochloride acts by blocking the kidney’s response to antidiuretic hormone, which helps normalize sodium levels. Standard diuretics rarely touch this problem, so the professional community values having another line of defense.
These practical experiences highlight why clinicians everywhere defend its place in formularies, even as hospitals chase cost savings by cutting inventory. Some view it as an “old drug,” but those sitting with patients in long-term care see its worth. When treating bacterial infections, it’s not just the compound’s presence but its steady hand that builds trust. Overuse of newer antibiotics increases resistance; Demeclocycline Hydrochloride, by being specific and not as widely deployed, avoids contributing as heavily to the resistance crisis.
No product stays on the market this long without building both allies and critics. Long-term use stories paint a picture of reliability and special utility. But the drawbacks—chiefly its sun-sensitivity, its effect on tooth and bone development in young children, and the possibility of gastrointestinal upset—cannot be glossed over. The professional community recognizes these risks and trains doctors and nurses to spot early warning signs. Proper patient education can head off most issues, teaching simple precautions like sun avoidance, taking the medicine with plenty of water, and spacing out dosing from calcium-rich foods or antacids.
Some challenges go beyond the patient bedside. Demeclocycline Hydrochloride occupies a space in treatment regimens that newer drugs try to squeeze out. Insurance coverage, hospital stocking decisions, and generic competition all shape its future. Recent discussions focus on balancing cost, patient need, and the growing problem of antibiotic resistance. Old drugs like this don’t dazzle with marketing campaigns, but word-of-mouth and real-world evidence keep them on the shelf.
Besides its role in infectious disease management, Demeclocycline Hydrochloride keeps a lower profile for non-infectious uses. Its effectiveness in SIADH creates a bridge between nephrology and infectious disease, adding value that goes beyond what’s common for antibiotics. Few drugs earn respect in both fields, yet experienced practitioners talk about its value in team meetings and treatment rounds.
I’ve worked alongside infectious disease teams and spent hours with pharmacists explaining the nuances of antibiotics. Many colleagues carry stories about cases where Demeclocycline Hydrochloride changed the equation—a stubborn UTI shaved days off a patient’s stay, or a complicated SIADH case finally stabilized. For those in the business of healing, these moments go beyond statistics or box labels. The story of this antibiotic goes hand in hand with patient stories, chart notes, and the day-to-day grind of clinical work.
Hospitals spending resources reviewing their formularies look for more than just cost metrics. They want peace of mind, knowing they’ve got reliable tools ready for the unexpected. Demeclocycline Hydrochloride doesn’t ask for the limelight, but its history, real-world performance, and cross-specialty impact make it hard to ignore. As the health system moves further into complex terrain, hanging onto these trusted tools feels less like nostalgia and more like preparation.
Antibiotic stewardship programs across the country push for smarter use of all antimicrobials. Demeclocycline Hydrochloride fits the strategy; it gets pulled off the shelf only when truly needed. Educating young clinicians about its right place keeps resistance problems in check and offers another layer of protection. More clear-headed training on its side effects and patient selection limits the reported negatives, such as skin reactions or gut irritation. Seasoned physicians and pharmacists pass along lessons through mentorship, building confidence in newcomers.
On the supply side, robust partnerships with manufacturers improve reliability and maintain quality standards. Scrutinizing every batch for purity, proper packaging, and potency guarantees patient safety. Pharmacy teams keep careful logs of stock movement, expiration, and usage trends, helping spot any problems early. By backing up these systems with solid oversight, the product’s reputation can survive pressures of lower-cost competitors and shifting market demands.
Closer collaboration between hospital teams—infectious disease, pharmacy, and nephrology—builds a more adaptive environment for smart antibiotic use. Demeclocycline Hydrochloride finds an audience with both specialists and generalists when people talk openly about unique, rare indications or share success stories at meetings. The more practitioners learn from each other’s practical experience, the smoother the patient journey gets.
Ensuring that every bottle and tablet holds up to quality expectations sits at the core of safe medicine. I’ve seen too many cases where shortcuts in production or sourcing lead to inconsistent results. Here, rigorous quality controls from trusted producers pay off in better outcomes and fewer surprises at the bedside. Regular audits of suppliers and ongoing checks of drug stability, package integrity, and labeling clarity support the goal of patient safety. Many health systems develop their own protocols to track the movement of Demeclocycline Hydrochloride in real time, quickly isolating any problems before they reach patients.
Access remains another challenge. In rural and resource-limited regions, steady access to this antibiotic isn’t always a given. Partnerships between larger hospital networks and smaller clinics can bridge some of the gap, making sure timely supplies reach everyone who needs them. By supporting advocacy efforts, clinicians can keep this product within reach for teams working outside big metropolitan centers.
The body of evidence around Demeclocycline Hydrochloride stretches back decades. Real-world data, medical journals, and lived patient stories all point to its value. People draw confidence not just from clinical trial results, but from the hundreds of thousands of patients who have taken it, improved, and shared their stories. It would be a mistake to overlook real clinical experience in favor of wallpapering over the story with statistics or marketing copy.
The landscape of antibiotic development keeps shifting, yet a drug like this stays relevant because the need never really leaves. Every year, pockets of resistance or allergy shut out newer, pricier alternatives. In these moments, practical knowledge—the shared wisdom built on rounds, in pharmacies, through tough cases—ushers in Demeclocycline Hydrochloride not as an afterthought, but as a worthy contender.
With all the fanfare that comes and goes in pharmaceutical marketing, there’s a constant in the quieter, day-to-day world of patient care: the need for drugs that work, withstand scrutiny, and don’t tear up budgets or patient safety. Demeclocycline Hydrochloride fits that description. Its model and specifications fade into the background against the landscape of its practical use, long-term safety, and real clinical evidence. As someone who spent years watching therapies come and go, I find value in products that lean on experience instead of hype.
The future of healthcare will always demand new solutions, new drugs, and faster innovation. But there’s a place reserved for those compounds that have weathered storms and still make sense to the professionals on the front lines. Demeclocycline Hydrochloride isn’t the answer to every problem, nor does it ask for top billing, but for the patients who have turned corners because of its presence, its value remains clear. The best medicine balances innovation with wisdom, never losing sight of what real-world experience teaches: sometimes, a steady hand means more than a shiny new tool.